Oppenheimer Maintains Outperform on Corteva, Raises Price Target to $95

Benzinga · 3d ago
Oppenheimer analyst Kristen Owen maintains Corteva (NYSE:CTVA) with a Outperform and raises the price target from $89 to $95.